Tigermed Announces Acquisition of Majority Stake in Shanghai Guanhe Pharmaceutical for CNY 140 Million
CompanyDeals

Tigermed Announces Acquisition of Majority Stake in Shanghai Guanhe Pharmaceutical for CNY 140 Million

China's National Healthcare Security Administration Issues Draft Guidelines for Long-Term Care Insurance
Policy / Regulatory

China’s National Healthcare Security Administration Issues Draft Guidelines for Long-Term Care Insurance

Insilico Medicine and Seto Biopartner to Leverage AI in Synthetic Biology and Drug Discovery
CompanyDeals

Insilico Medicine and Seto Biopartner to Leverage AI in Synthetic Biology and Drug Discovery

China's CDE Releases Draft Guidelines for Biosimilar Drug Labeling
Policy / Regulatory

China’s CDE Releases Draft Guidelines for Biosimilar Drug Labeling

Legend Biotech Corporation
CompanyR&D

Legend Biotech Corporation to Establish Advanced R&D Center in Philadelphia for Next-Generation Cell Therapies

BeiGene
CompanyDrug

BeiGene Prices TEVIMBRA 10% Below Competitors Following FDA Approval for Esophageal Cancer Treatment

Unixell Biotechnology
CompanyDrug

Unixell Advances in Cell Therapy with CDE IND Acceptance

Duality Biotherapeutics
CompanyDrug

Duality Biotherapeutics’ BDCA2 ADC DB-2304 Phase I Trial Registered on ClinicalTrials.gov

BeiGene
CompanyDrug

BeiGene’s FGFR2b ADC BG-C137 Enters Phase I Clinical Trial for Advanced Solid Tumors

Bristol Myers Squibb
CompanyDrug

BMS Expands Opdivo Indication with FDA Approval for NSCLC Combo Therapy

InnoCare Pharma
CompanyDrug

InnoCare Pharma’s Orelabrutinib Achieves Milestone in SLE Clinical Trial Enrollment

Akeso Biopharma
CompanyDrug

Akeso Biopharma’s PD-1/VEGF Bispecific Antibody Study Completes Enrollment